Novadip Biosciences, a Mont Saint-Guibert, Belgium-based late-stage clinical biotechnology company specializing in regenerative medicine, closed a funding round of €10.4m ($11.98m) in convertible financing. The round was led by New Science Ventures with the support of Fund+, Wallonie Entreprendre, VIVES Fund, ORSA Tech, Sambrinvest, Noshaq and Invest.BW. Adding to a previous €9.6m convertible loan secured last year, this round brought the convertible financing to a total of €20m ($23.3m). The co...See more